Rani Therapeutics hauls in $53 mln
Rani Therapeutics, a developer of a pill designed to replace injectable drug delivery for patients suffering from chronic diseases, has raised $53 million in funding. The investors included GeneScience Pharmaceuticals, Bossa Ventures, Cathay Venture Inc, GV, Alphabet Inc's investment arm, Novartis, AstraZeneca, Ping An Ventures and Virtus Ventures.
8 February 2018•1 min read
